AVIR

Atea Pharmaceuticals to Present at William Blair Biotech Focus Conference

Atea Pharma's AT-527 Rapidly Reduces Viral Load Levels In Hospitalized COVID-19 Patients

Atea Pharma Secures AT-527-Related Milestone Payment Of $50M From Roche

Atea Pharmaceuticals Announces Achievement of AT-527 Development Milestone Under License Agreement with Roche

Atea Pharmaceuticals Appoints Claudio Avila, MB, BS, Ph.D., as Senior Vice President of Medical Affairs

Atea Pharmaceuticals Appoints Jerome Adams, M.D., M.P.H., to Board of Directors

Atea Pharmaceuticals, Inc.'s (AVIR) CEO Jean-Pierre Sommadossi on Q1 2021 Results - Earnings Call Transcript